✦ LIBER ✦

P1299 PEARL-III: 12 WEEKS OF ABT-450/R/267 + ABT-333 ACHIEVED SVR IN >99% OF 419 TREATMENT-NAIVE HCV GENOTYPE 1B-INFECTED ADULTS WITH OR WITHOUT RIBAVIRIN

✍ Scribed by Ferenci, P.; Nyberg, A.; Enayati, P.; Bernstein, D.; Baruch, Y.; Caruntu, F.A.; Chulanov, V.; Janczewska, E.; Younes, Z.; Marinho, R.T.; Rizzardini, G.; Gervain, J.; Planas, R.; Moreno, C.; Xie, W.; Cohen, D.; King, M.; Podsadecki, T.; Reddy, K.R.

Book ID: 122262489
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 62 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61466-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Su1061 Pearl-IV: a 12-Week Regimen of AB

Su1061 Pearl-IV: a 12-Week Regimen of ABT-450/r/ABT-267 and ABT-333, With or Without Ribavirin Achieves Svr12 Rates≥90% in Treatment-Naïve Adults Infected With Hepatitis C Virus Genotype 1A

✍ Bernstein, David; Lalezari, Jacob; Luo, Yan; Box, Terry D.; Younes, Ziad H.; Gre 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 544 KB

1399 12-WEEK INTERFERON-FREE REGIMEN OF

1399 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R +ABT-333 +RIBAVIRIN ACHIEVED SVR12 IN MORE THAN 90% OF TREATMENT-NAIVE HCV GENOTYPE-1-INFECTED SUBJECTS AND 47% OF PREVIOUS NON-RESPONDERS

✍ Poordad, F.; Lawitz, E.; Kowdley, K.V.; Everson, G.T.; Freilich, B.; Cohen, D.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 179 KB

929e PEARL-II: Randomized Phase 3 Trial

929e PEARL-II: Randomized Phase 3 Trial of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333 With or Without Ribavirin in Hepatitis C Virus Genotype 1b-Infected, Treatment-Experienced Patients

✍ Andreone, Pietro; Colombo, Massimo; Enejosa, Jeffrey V.; Koksal, Iftihar; Ferenc 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

514 Interferon-Free Regimens of Abt-450/

514 Interferon-Free Regimens of Abt-450/R, Abt-267, Abt-333, and Ribavirin Achieve High Sustained Virologic Response 4 Weeks Post-Treatment (SVR4) Rates in Patients With Chronic HCV Genotype 1 Regardless of Race, Ethnicity, or Other Baseline Characteristics

✍ Rodriguez-Torres, Maribel; Nunes, Frederick; Cohen, Daniel; Xie, Wangang; Marinc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 376 KB

O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLL

O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333, AND RIBAVIRIN IN 631 TREATMENT-NAIVE ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1

✍ Feld, J.J.; Kowdley, K.V.; Coakley, E.; Sigal, S.; Nelson, D.; Crawford, D.; Wei 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

13 A 12-WEEK INTERFERON-FREE REGIMEN OF

13 A 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R, ABT-072, AND RIBAVIRIN WAS WELL TOLERATED AND ACHIEVED SUSTAINED VIROLOGIC RESPONSE IN 91% TREATMENT-NAIVE HCV IL28B-CC GENOTYPE-1-INFECTED SUBJECTS

✍ E. Lawitz; F. Poordad; K.V. Kowdley; D. Jensen; D.E. Cohen; S. Siggelkow; K. Wik 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 105 KB